Immunocore Holdings (IMCR) Non-Current Deffered Revenue (2022 - 2025)
Historic Non-Current Deffered Revenue for Immunocore Holdings (IMCR) over the last 4 years, with Q3 2025 value amounting to $5.0 million.
- Immunocore Holdings' Non-Current Deffered Revenue fell 1383.47% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year decrease of 1383.47%. This contributed to the annual value of $5.4 million for FY2024, which is 146.87% down from last year.
- Per Immunocore Holdings' latest filing, its Non-Current Deffered Revenue stood at $5.0 million for Q3 2025, which was down 1383.47% from $5.2 million recorded in Q2 2025.
- In the past 5 years, Immunocore Holdings' Non-Current Deffered Revenue registered a high of $5.8 million during Q3 2024, and its lowest value of $5.0 million during Q3 2025.
- Moreover, its 4-year median value for Non-Current Deffered Revenue was $5.5 million (2024), whereas its average is $5.4 million.
- As far as peak fluctuations go, Immunocore Holdings' Non-Current Deffered Revenue soared by 520.79% in 2023, and later tumbled by 1383.47% in 2025.
- Quarter analysis of 4 years shows Immunocore Holdings' Non-Current Deffered Revenue stood at $5.2 million in 2022, then rose by 5.21% to $5.5 million in 2023, then dropped by 1.47% to $5.4 million in 2024, then fell by 8.08% to $5.0 million in 2025.
- Its Non-Current Deffered Revenue was $5.0 million in Q3 2025, compared to $5.2 million in Q2 2025 and $5.6 million in Q1 2025.